Pilot Study on Device-assisted Mobilisation of Critically Ill Patients
LIANA-I
Randomised Pilot Study on Device-assisted Mobilisation With a Sit/Stand Stabiliser of Critically Ill Patients With Ventilatory Support
1 other identifier
interventional
40
1 country
1
Brief Summary
This Pilot study will hypothesize that patients with organ insufficiency and breathing assistance in our post-anaesthesia care unit (PACU) and ICU will be mobilized more often to an ICU mobility scale (IMS) ≥ 4 (i.e. standing) using the Liana® mobilizer. Therefore a randomized controlled pilot study will be conducted. The aim is to achieve an important physical function mile stone more often using this device. Secondary hypotheses are:
- 1.The intervention will relieve the burden of the health care staff in the unit
- 2.The intervention will positively influence the functional outcome of critically ill patients
- 3.The intervention is perceived as positive by the patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedStudy Start
First participant enrolled
April 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2025
CompletedDecember 15, 2025
December 1, 2025
1.9 years
January 28, 2023
December 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Level of mobilisation (IMS)
Mean level of mobilisation measured with the Intensive Car Unit Mobility Scale (IMS) till ICU discharge (or Day 28); IMS ranges from 0 (no mobilization) to 10 (independent walking)
28 Days
Secondary Outcomes (17)
Frequency of IMS ≥ 4
28 Days
Handgrip strength
28 Days
MRC Sum Score
28 Days
Diaphragma function
28 Days
CPAx Score
28 Days
- +12 more secondary outcomes
Study Arms (2)
Intervention Group
EXPERIMENTALMobilization incl. support by the Liana. In the intervention group, Liana is used to train trunk stability in a sitting position. If this is successful, the patient is trained to stand. Mobilization to higher levels is performed according to clinical standards.
Control Group
NO INTERVENTIONStandard of Care without the use of the Liana. In the control group the therapy is carried out according to the ward standard without using the Liana.
Interventions
Non-invasive device-assisted mobilisation with LIANA
Eligibility Criteria
You may qualify if:
- Intensive care patient with ventilatory support and an expected intensive care stay of at least another 48 h
- Age ≥ 18 years
- Current length of intensive care stay \< 48 h
You may not qualify if:
- Moribund and critically ill
- Suspected 6-month mortality \> 75%.
- Increased intracranial pressure
- Critically ill after cardiopulmonary resuscitation
- Critically ill with primary neuromuscular disease or motor neuron disease
- One or more amputated extremities
- Patients, within 2h after surgery
- Unstable fractures
- Severe traumatic brain injury (e.g., brain and skull injuries)
- Circulatory instability with norepinephrine \> 0.3 µg/kg/min
- Patients for whom there is an indication for deep sedation (RASS -5)
- Language barrier
- Fitting of legs into leg trays is not possible due to e.g. patient weight
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité - Univiversitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan J Schaller, MD
Charite University, Berlin, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Clinical Director
Study Record Dates
First Submitted
January 28, 2023
First Posted
February 8, 2023
Study Start
April 27, 2023
Primary Completion
April 4, 2025
Study Completion
November 11, 2025
Last Updated
December 15, 2025
Record last verified: 2025-12